StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP stock opened at $6.96 on Friday. Titan Pharmaceuticals has a 12 month low of $5.00 and […]
Related Keywords
United States , Canada , , Titan Pharmaceuticals Company Profile , Virtu Financial , Titan Pharmaceuticals Price Performance , Titan Pharmaceuticals Inc , Institutional Investors Weigh In On Titan Pharmaceuticals , Titan Pharmaceuticals , Renaissance Technologies , Millennium Management , European Union , News Ratings For Titan Pharmaceuticals Daily , Free Report , Street Corp , Get Free Report , Titan Pharmaceuticals Daily , Nasdaq Ttnp , Ttnp , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.